Ramosetron

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Ramosetron
Ramosetron.svg
Clinical data
AHFS/Drugs.com International Drug Names
Routes of
administration
By mouth (ODT), IV
ATC code
  • None
Pharmacokinetic data
Biological half-life 5.8 hours
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
KEGG
ChEMBL
ECHA InfoCard 100.217.075
Chemical and physical data
Formula C17H17N3O
Molar mass 279.33 g/mol
3D model (JSmol)
 NYesY (what is this?)  (verify)

Ramosetron (INN) is a serotonin 5-HT3 receptor antagonist for the treatment of nausea and vomiting.[1] Ramosetron is also indicated for a treatment of "diarrhea-predominant irritable bowel syndrome in males".[2] In India it is marketed under the brand name of IBset.

It is only licensed for use in Japan and selected Southeast Asian countries. In Japan it is sold under the trade name Iribo.[3] Elsewhere it is commonly sold under the trade name Nasea and in India as Nozia (150 μg/mL injection & 100 μg oral tablet).[4]

References[edit]